MARKET

AMRS

AMRS

Amyris
NASDAQ

Real-time Quotes | Nasdaq Last Sale

12.22
+0.81
+7.10%
After Hours: 12.22 0 0.00% 19:57 05/07 EDT
OPEN
11.61
PREV CLOSE
11.41
HIGH
12.80
LOW
11.50
VOLUME
4.54M
TURNOVER
--
52 WEEK HIGH
23.42
52 WEEK LOW
1.875
MARKET CAP
3.34B
P/E (TTM)
-7.1026
1D
5D
1M
3M
1Y
5Y
10-Q: AMYRIS, INC.
Edgar Online - (EDG = 10Q, 10K) · 1d ago
Synthetic Biology Market Research Report and Predictive Business Strategy By 2027
May 07, 2021 (Heraldkeepers) -- The synthetic biology market is segmented on the lines of its product, technology and application. The synthetic biology is...
Heraldkeepers · 1d ago
Analysts Offer Insights on Materials Companies: Amyris (AMRS) and Golden Minerals Co (AUMN)
There's a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Amyris (AMRS) and Golden Minerals Co (AUMN) with bullish
SmarterAnalyst · 2d ago
72 Biggest Movers From Yesterday
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 85.8% to settle at $10.22 on above-average volume.
Benzinga · 2d ago
Oppenheimer Sticks to Its Buy Rating for Amyris (AMRS)
In a report released today, Colin Rusch from Oppenheimer maintained a Buy rating on Amyris (AMRS), with a price target of $25.00. The company's shares
SmarterAnalyst · 2d ago
Hecla Mining, Corvus Gold lead energy gainers; U.S. Concrete, Venator Materials among major losers
Gainers: Hecla Mining (HL) +16%, Corvus Gold (KOR) +13%, Endeavour Silver (EXK) +13%, Hudson Technologies (HDSN) +12%, SSR Mining (SSRM) +10%.Losers: U.S. Concrete (USCR) -20%, Venator Materials (VNTR) -19%, Laredo Petroleum (LPI) -18%, Century Aluminum (C...
Seekingalpha · 2d ago
8-K: AMYRIS, INC.
(EDGAR Online via COMTEX) -- 0001365916FALSE00013659162021-05-062021-05-06 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 2d ago
Amyris, Inc. (AMRS) Reports Q1 Loss, Tops Revenue Estimates
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -575.00% and 367.23%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AMRS. Analyze the recent business situations of Amyris through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AMRS stock price target is 24.40 with a high estimate of 35.00 and a low estimate of 17.00.
EPS
Institutional Holdings
Institutions: 171
Institutional Holdings: 100.16M
% Owned: 36.65%
Shares Outstanding: 273.27M
TypeInstitutionsShares
Increased
52
14.80M
New
39
7.13M
Decreased
16
7.78M
Sold Out
18
18.81M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Commodity Chemicals
+0.69%
Chemicals
+0.98%
Key Executives
Chairman/Independent Director
Geoffrey Duyk
Chief Executive Officer/President/Director
John Melo
Corporate Executive
Oreste Fieschi
Chief Financial Officer
Han Kieftenbeld
Chief Operating Officer
Eduardo Alvarez
Chief Accounting Officer
Anthony Hughes
Chief Marketing Officer
Sheila Pollak
General Counsel/Secretary
Nicole Kelsey
Other
Francisco Costa
Other
Kathleen Valiasek
Director
Philip Eykerman
Director
Julie Washington
Independent Director
John Doerr
Independent Director
Frank Kung
Independent Director
James McCann
Independent Director
Steven Mills
Independent Director
Carole Piwnica
Independent Director
Lisa Qi
Independent Director
Patrick Yang
No Data
About AMRS
Amyris, Inc. is an industrial biotechnology company. The Company is primarily focused on applying its technology platform to engineer, manufacture and sell high performance, natural, sustainably-sourced products into the Health & Wellness, Clean Beauty, and Flavor and Fragrance markets. Its technology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into volume, high-value ingredients. Its biotechnology platform and industrial fermentation process replace existing complex and expensive manufacturing processes. The Company’s platform is used to design, build, optimize and upscale strains producing eight distinct molecules at commercial volumes, to more than 15 commercial ingredients.

Webull offers kinds of Amyris Inc stock information, including NASDAQ:AMRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMRS stock methods without spending real money on the virtual paper trading platform.